Cell Therapy Market Research Report by Cell Type, Therapy Type, Application, End-User, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19

The North America Cell Therapy Market size was estimated at USD 1,836.33 million in 2021 and expected to reach USD 2,026.41 million in 2022, and is projected to grow at a CAGR 10.78% to reach USD 3,394.19 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Cell Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Cell Type, the market was studied across Differentiated Cell and Stem Cell.

Based on Therapy Type, the market was studied across Allogenic Therapies and Autologous Therapies.

Based on Application, the market was studied across Autoimmune Diseases, Dermatology, Musculoskeletal Therapies, and Oncology.

Based on End-User, the market was studied across Biotechnology and Pharmaceutical Companies, Hospitals and Clinics, and Research Institutes.

Based on Country, the market was studied across Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell Therapy market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Therapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the North America Cell Therapy Market, including Anterogen Co., Ltd., Astellas Pharma Inc., BioNTech SE, Bristol-Myers Squibb Company, Castle Creek Biosciences, Inc., FUJIFILM Holdings Corporation, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc., Lonza Group Ltd., Medipost Co., Ltd., Novartis AG, NuVasive, Inc., Pfizer Inc., Sartorius AG, Smith & Nephew PLC, Stemedica Cell Technologies, Inc., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Inc., and Vericel Corporation.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the North America Cell Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the North America Cell Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the North America Cell Therapy Market?
4. What is the competitive strategic window for opportunities in the North America Cell Therapy Market?
5. What are the technology trends and regulatory frameworks in the North America Cell Therapy Market?
6. What is the market share of the leading vendors in the North America Cell Therapy Market?
7. What modes and strategic moves are considered suitable for entering the North America Cell Therapy Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Cell Therapy Market, by Cell Type
6.1. Introduction
6.2. Differentiated Cell
6.3. Stem Cell

7. Cell Therapy Market, by Therapy Type
7.1. Introduction
7.2. Allogenic Therapies
7.3. Autologous Therapies

8. Cell Therapy Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Dermatology
8.4. Musculoskeletal Therapies
8.5. Oncology

9. Cell Therapy Market, by End-User
9.1. Introduction
9.2. Biotechnology and Pharmaceutical Companies
9.3. Hospitals and Clinics
9.4. Research Institutes

10. Canada Cell Therapy Market
10.1. Introduction

11. Mexico Cell Therapy Market
11.1. Introduction

12. United States Cell Therapy Market
12.1. Introduction

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Anterogen Co., Ltd.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Astellas Pharma Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. BioNTech SE
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Bristol-Myers Squibb Company
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Castle Creek Biosciences, Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. FUJIFILM Holdings Corporation
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Gilead Sciences, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. JCR Pharmaceuticals Co., Ltd.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Kolon TissueGene, Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Lonza Group Ltd.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Medipost Co., Ltd.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Novartis AG
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. NuVasive, Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Pfizer Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Sartorius AG
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Smith & Nephew PLC
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Stemedica Cell Technologies, Inc.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Takeda Pharmaceutical Company Limited
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Thermo Fisher Scientific, Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Vericel Corporation
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing